Health & bio

Next-Generation GLP-1 Candidates Target Expanded Pathways

New drug candidates beyond GLP-1 targeting neurological and metabolic pathways emerging.

Primary sources · 1
STAT
← View the full 2026-04-24 (Fri) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →